Clinical trial
Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients
NCT00123643 · St. Paul Heart Clinic, Other · Completed
Key facts
| NCT number | NCT00123643 |
|---|---|
| Title | Vascular Effects of Rosiglitazone Versus Glyburide in Type 2 Diabetic Patients |
| Official title | Comparison of Rosiglitazone Versus Glyburide on Vascular Structure and Function in Type 2 Diabetic Patients |
| Lead sponsor | St. Paul Heart Clinic, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | rosiglitazone, glyburide |
| Enrollment | 36 |
| Start date | May 1, 2003 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Jul 25, 2005 |
| Last update posted | Jul 15, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: